BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 31852789)

  • 1. Flow Cytometry Analysis of HIV-1 Env Conformations at the Surface of Infected Cells and Virions: Role of Nef, CD4, and SERINC5.
    Staropoli I; Dufloo J; Ducher A; Commere PH; Sartori-Rupp A; Novault S; Bruel T; Lorin V; Mouquet H; Schwartz O; Casartelli N
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of HIV-1 Env on SERINC5 Antagonism.
    Beitari S; Ding S; Pan Q; Finzi A; Liang C
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SERINC5 Inhibits HIV-1 Infectivity by Altering the Conformation of gp120 on HIV-1 Particles.
    Featherstone A; Aiken C
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32796070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
    Trautz B; Pierini V; Wombacher R; Stolp B; Chase AJ; Pizzato M; Fackler OT
    J Virol; 2016 Dec; 90(23):10915-10927. PubMed ID: 27681140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Nef-mediated CD3 down-regulation in the HIV-1 lineage increases viral infectivity and spread.
    Mesner D; Hotter D; Kirchhoff F; Jolly C
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7382-7391. PubMed ID: 32179688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 Incorporation into HIV-1 Viral Particles Exposes Envelope Epitopes Recognized by CD4-Induced Antibodies.
    Ding S; Gasser R; Gendron-Lepage G; Medjahed H; Tolbert WD; Sodroski J; Pazgier M; Finzi A
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31484748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 Expression and Env Conformation Are Critical for HIV-1 Restriction by SERINC5.
    Zhang X; Shi J; Qiu X; Chai Q; Frabutt DA; Schwartz RC; Zheng YH
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31043528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural HIV-1 Nef Polymorphisms Impair SERINC5 Downregulation Activity.
    Jin SW; Alsahafi N; Kuang XT; Swann SA; Toyoda M; Göttlinger H; Walker BD; Ueno T; Finzi A; Brumme ZL; Brockman MA
    Cell Rep; 2019 Nov; 29(6):1449-1457.e5. PubMed ID: 31693887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Amino Acid Polymorphism within the HIV-1 Nef Dileucine Motif Functionally Uncouples Cell Surface CD4 and SERINC5 Downregulation.
    Mumby MJ; Johnson AL; Trothen SM; Edgar CR; Gibson R; Stathopulos PB; Arts EJ; Dikeakos JD
    J Virol; 2021 Jul; 95(16):e0058821. PubMed ID: 34037423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.
    Veillette M; Désormeaux A; Medjahed H; Gharsallah NE; Coutu M; Baalwa J; Guan Y; Lewis G; Ferrari G; Hahn BH; Haynes BF; Robinson JE; Kaufmann DE; Bonsignori M; Sodroski J; Finzi A
    J Virol; 2014 Mar; 88(5):2633-44. PubMed ID: 24352444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.
    Trautz B; Wiedemann H; Lüchtenborg C; Pierini V; Kranich J; Glass B; Kräusslich HG; Brocker T; Pizzato M; Ruggieri A; Brügger B; Fackler OT
    J Biol Chem; 2017 Aug; 292(33):13702-13713. PubMed ID: 28659343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States.
    Heredia JD; Park J; Choi H; Gill KS; Procko E
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.
    Pizzato M; Popova E; Göttlinger HG
    J Virol; 2008 Nov; 82(21):10811-9. PubMed ID: 18715908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells.
    Wang Q; Zhang S; Nguyen HT; Sodroski J
    J Virol; 2024 Feb; 98(2):e0159423. PubMed ID: 38289101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.
    Zhang S; Nguyen HT; Ding H; Wang J; Zou S; Liu L; Guha D; Gabuzda D; Ho DD; Kappes JC; Sodroski J
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33148792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nef homodimers down-regulate SERINC5 by AP-2-mediated endocytosis to promote HIV-1 infectivity.
    Staudt RP; Smithgall TE
    J Biol Chem; 2020 Nov; 295(46):15540-15552. PubMed ID: 32873704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.
    Prévost J; Richard J; Medjahed H; Alexander A; Jones J; Kappes JC; Ochsenbauer C; Finzi A
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity to monoclonal antibody 447-52D and an open env trimer conformation correlate poorly with inhibition of HIV-1 infectivity by SERINC5.
    Angerstein AO; Stoneham CA; Ramirez PW; Guatelli JC; Vollbrecht T
    Virology; 2020 Sep; 548():73-81. PubMed ID: 32838948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SERINC5 Can Enhance Proinflammatory Cytokine Production by Primary Human Myeloid Cells in Response to Challenge with HIV-1 Particles.
    Pierini V; Gallucci L; Stürzel CM; Kirchhoff F; Fackler OT
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.
    Sood C; Marin M; Chande A; Pizzato M; Melikyan GB
    J Biol Chem; 2017 Apr; 292(14):6014-6026. PubMed ID: 28179429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.